How many insider declarations does 博瑞医药 have?

博瑞医药 has filed 1 insider declaration with AMF.

Who is the top reporting insider at 博瑞医药?

The top reporting insider at 博瑞医药 is 程增江, based on the count of public filings.

What is the net insider buy vs sell volume on 博瑞医药?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

博

博瑞医药: insider trades · France · AMF

SSE:688166FR·AMFMcap 20.8Bn€

AMF ↗

Discover the full insider trade history of 博瑞医药, a publicly traded company based in France. Shares are quoted on FR FR, under the oversight of AMF. Market capitalisation: €20.8bn. The latest transaction was filed on 18 November 2024 (Purchase). Among the most active insiders: 程增江. The full history is accessible without an account.

1

Insider Decl.

0

Thresholds

·

1 ops.

Buy Volume

·

0 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

61.37 €

Income statement

Revenue1.22 Bn€

Gross profit622.0 M€51% margin

Net income54.5 M€4.5% margin

Balance sheet & cash

Market cap20.76 Bn€

Total debt2.35 Bn€

Free Cash Flow−128.2 M€

Last declaration on 18 November 2024

All Executives1 Thresholds Prospectus Other

Declarations1 total

Executives●Purchase7SSE

程

程增江董事

3,000 shares

A股XSHG

SSE:173000008276334900·18 Nov 2024

Ideal exit: 15 Aug 2025 (T+270)

SSE ↗

1 of 1 declaration